Manuel F Llano, Age 60El Paso, TX

2010029, Nov 18, 2010

May 13, 2010

12/779154

Manuel Llano - El Paso TX, US
Elisa Morales - El Paso TX, US

BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM - Austin TX

C12Q 1/48

435 15

The development and validation of a cell-based, homogeneous high throughput screening (HTS) assay for small compounds inhibiting the HIV integrase-LEDGF/p75 interaction is described herein. The HTS strategy has the potential to identify small-molecules interfering with the interaction of HIV integrase-LEDGF/p75. These small molecules represent starting scaffolds for therapeutic drug development.

2018003, Feb 8, 2018

Mar 10, 2016

15/555842

Luis A. ECHEGOYEN - El Paso TX, US
Manuel LLANO - El Paso TX, US
Edison A. CASTRO-PORTILLO - El Paso TX, US
Zachary MARTINEZ - El Paso TX, US

THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX

C07D 209/94
A61K 31/403

Certain embodiments are directed to Cfullerene derivatives N-N-dimethyl [70]fulleropyrrolidinium iodide. Certain further embodiments are directed to α, β and γ isomer of N-N-dimethyl[70]fulleropyrrolidinium iodide.

2017019, Jul 13, 2017

Nov 4, 2016

15/343631

Luis A. Echegoyen - El Paso TX, US
Danisha M. Rivera-Nazario - El Paso TX, US
Edison A. Castro Portillo - El Paso TX, US
Zachary Martinez - El Paso TX, US
Manuel Llano - El Paso TX, US

THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM - Austin TX

C07D 513/04
C07D 519/00

Certain embodiments are directed to fullerene derivatives tetrahydro-1H—C-fulleropyrrolo[1,2-c][1,3]thiazine salts (Formula I) or tetrahydro-1H—C-fulleropyrrolo[1,2-c][1,3]thiazine salts (Formula II). Certain further embodiments are directed to α, β, γ, and/or δ isomer of tetrahydro-1H—C-fulleropyrrolo[1,2-c][1,3]thiazine salt.